BioXcel Therapeutics (BTAI) PT Raised to $120 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $120.00 (from $95.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
